What is Thyme Care?
Thyme Care operates as a premier oncology navigation leader, bridging the gap between complex cancer care delivery and patient accessibility. By deploying expert oncology teams that provide 24/7 virtual support, the company addresses critical pain points in the cancer journey, including affordability, care coordination, and communication. Their business model relies on strategic partnerships with health plans, oncology groups, and primary care providers to streamline the patient experience. By proactively managing care pathways, Thyme Care effectively reduces systemic healthcare costs while simultaneously improving clinical outcomes for members, establishing itself as a vital infrastructure layer in modern oncology management.
How much funding has Thyme Care raised?
Thyme Care has raised a total of $371M across 5 funding rounds:
Unspecified
$22M
Series B
$60M
Series C
$95M
Private Equity
$97M
Series D
$97M
Unspecified (2021): $22M with participation from Frist Cressey Ventures, Casdin Capital, Andreessen Horowitz, AlleyCorp companies, and Bessemer Venture Partners
Series B (2023): $60M led by Frist Cressey Ventures, Town Hall Ventures, Foresite Capital, Casdin Capital, AlleyCorp, and Andreessen Horowitz
Series C (2024): $95M supported by Frist Cressey Ventures, Concord Health Partners, and Andreessen Horowitz
Series D (2025): $97M featuring Humana, Concord Health Partners, Texas Oncology, Andreessen Horowitz, Town Hall Ventures, Memorial Hermann Health Plan, AlleyCorp companies, JPMorgan Chase, Foresite Capital, CVS Health, and Frist Cressey Ventures
Private Equity (2025): $97M, investors not publicly disclosed
Key Investors in Thyme Care
Frist Cressey Ventures
A venture capital firm dedicated to accelerating the growth of innovative companies that are transforming healthcare through systemic improvements.
Andreessen Horowitz
A prominent private American venture capital firm that invests in both early-stage start-ups and established growth companies across various technology sectors.
Foresite Capital
A multi-stage investment firm focused on transforming healthcare by investing in companies that utilize biology and big data to address unmet needs.
What's next for Thyme Care?
Following this significant capital infusion, Thyme Care is poised to accelerate its market penetration and enhance its technological infrastructure. The company's strategic roadmap likely involves expanding its network of health plan partners and deepening its integration with existing oncology care providers. As the firm moves beyond its current growth stage, the focus will shift toward optimizing its virtual navigation platform to handle increased member volume. By leveraging its robust backing from industry-leading investors, Thyme Care is set to redefine the standard of care for cancer patients, driving long-term value through improved health outcomes and operational efficiency across the oncology landscape.
See full Thyme Care company page
